T. Schneider
Papers
1
Total Citations
152
H-Index
1
About
T. Schneider has established a significant presence in the field of radiation oncology, with particular expertise in stereotactic body radiotherapy (SBRT) for the treatment of oligometastatic disease. Their most notable contribution comes through leadership in the DEGRO SBRT database initiative, a landmark multicenter effort that pooled clinical data from across Germany to rigorously evaluate outcomes in liver oligometastases treatment. This 2018 study, analyzing 474 patients and 623 metastases, has garnered 152 citations, underscoring its influence in shaping evidence-based protocols for a rapidly evolving treatment modality. By identifying key factors influencing local metastases control and overall survival, Schneider's work has helped clinicians make more informed decisions about patient selection and treatment planning for SBRT — a precise, high-dose radiation technique increasingly used as an alternative to surgery. Their contributions to patterns-of-care research are particularly valuable, bridging the gap between institutional practice variation and standardized, outcome-driven guidelines. Schneider's work continues to serve as an important reference point for radiation oncologists treating patients with limited metastatic disease.
Research Focus
Key Achievements
Top Papers
- 1